Impact of beta blocker medication on survival outcome of ovarian cancer: A nationwide population-based cohort study.

被引：0
|
作者：
Park, Jeong-Yeol
Baek, Min-Hyun
Park, Young-Han
Kim, Dae-Yeon
Suh, Dae-Shik
Kim, Jong-Hyeok
Kim, Yong-Man
Kim, Young-Tak
Nam, Joo-Hyun
机构：
[1] Univ Ulsan, Dept Obstet & Gynecol, Coll Med, Asan Med Ctr, Seoul, South Korea
[2] Univ Ulsan, Dept Obstet & Gynecol, Coll Med, Asan Med Ctr, Anyang, South Korea
[3] Hallym Univ, Sacred Heart Hosp, Dept Obstet & Gynecol, Anyang, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.5578
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5578
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of metformin on survival outcome in ovarian cancer: a nationwide population-based cohort study
    Park, Jeong-Yeol
    Lim, Myong Cheol
    Baek, Min-Hyun
    Park, Young-Han
    Kim, Seonok
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2021, 32 (04)
  • [2] Impact of metformin on survival outcome in ovarian cancer: A nationwide population-based cohort study
    Baek, M. H.
    Park, Y. H.
    Kim, H. B.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 42 - 42
  • [3] Impact of beta blockers on survival outcomes in ovarian cancer: a nationwide population-based cohort study
    Baek, Min-Hyun
    Kim, Dae-Yeon
    Kim, Seon Ok
    Kim, Ye-Jee
    Park, Young-Han
    [J]. JOURNAL OF GYNECOLOGIC ONCOLOGY, 2018, 29 (06)
  • [4] Impact of beta blockers on survival outcomes in ovarian cancer: A nationwide population-based cohort study
    Baek, M. H.
    Park, Y. H.
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 154 : 226 - 227
  • [5] Beta-blocker use and survival after pancreatic cancer surgery: A nationwide population-based cohort study
    Kirkegard, Jakob
    Cronin-Fenton, Deirdre
    Lund, Andrea
    Mortensen, Frank Viborg
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [6] Impact of statins on the survival of patients with cancer: a nationwide population-based cohort study in South Korea
    Ahn, Juhee
    Won, Sungho
    Lee, Sanghun
    [J]. CANCER COMMUNICATIONS, 2022, 42 (02) : 184 - 187
  • [7] Beta blocker use and ovarian cancer survival: A retrospective cohort study
    Eskander, R.
    Randall, L.
    Bessonova, L.
    Ward, K.
    Culver, H. Anton
    Harrison, T.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 125 : S111 - S111
  • [8] Beta blocker use and ovarian cancer survival: A retrospective cohort study
    Eskander, R.
    Bessonova, L.
    Chiu, C.
    Ward, K.
    Culver, H.
    Harrison, T.
    Randall, L.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S21 - S21
  • [9] Epidemiologic risk factors and survival trajectories among epithelial ovarian cancer survivors: A population-based cohort study.
    Kim, Shana Jean
    Rosen, Barry
    McLaughlin, John R.
    Risch, Harvey
    Tworoger, Shelly S.
    Narod, Steven A.
    Kotsopoulos, Joanne
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [10] Textbook outcome as a composite outcome measure to compare hospital performances regarding cytoreductive surgery for ovarian cancer: A nationwide population-based study.
    Algera, M. D.
    Slangen, B. F. M.
    van Driel, W. J.
    Wouters, M. W. J. M.
    Kruitwagen, R. F. P. M.
    [J]. GYNECOLOGIC ONCOLOGY, 2023, 174 : 89 - 97
12345